Trump executive order presents challenges for workers’ comp, auto insurers

Lastly, the order imposes significant tariffs on pharmaceutical imports, particularly targeting drugs from Canada, Mexico and China, with the intention of bringing drug production back to the United States.

Impact on workers’ compensation insurers

Workers’ compensation insurers are likely to face several challenges due to these changes. The delay in Medicare drug price negotiations and the timing of tariffs may lead to higher drug prices, potentially increasing overall expenses for insurers who cover medication costs for injured employees. Additionally, the focus on bringing drug production back to the U.S. might lead to supply chain disruptions, resulting in temporary shortages or delays in the availability of certain medications.

However, the elimination of the “pill penalty” could spur innovation in small molecule drugs, potentially leading to new and more effective treatment options for injured employees. While this presents a positive outlook for the future, it’s important to note the benefits of these innovations may take time to materialize.

Impact on auto insurers

Like workers’ compensation insurers, auto insurers who cover medical expenses from car accidents may face similar challenges. The delay in price negotiations and implementation of tariffs could drive up medication costs, while international supply chain disruptions might create shortages of essential medicines. However, there are some positive aspects to consider.

The industry’s increased focus on small molecule drug innovation could eventually provide better treatment options for those involved in auto accident injuries. Additionally, although price increases are a concern, several factors will likely slow their impact. These include existing fee schedules, average wholesale price (AWP) establishment, and the Consumer Price Index (CPI), all of which typically respond gradually to market changes.

Strategies for insurers

To navigate these changes, insurers can consider several strategies. Enhancing risk assessment and pricing models to account for potential increases in drug costs and supply chain disruptions will be crucial. Regular review and updates of policies can help ensure they reflect the current health care landscape and regulatory environment.

Maintaining open lines of communication with policyholders, health care providers, and regulators can help insurers stay informed about changes and address any concerns promptly. Leveraging technology, such as advanced analytics and artificial intelligence, may improve risk management, claim processing, and customer service. It’s also vital for insurers to stay informed on regulations and actively participate in industry discussions to advocate for policies that support the insurance sector.

In addition to these strategies, insurers should consider leveraging advanced bill review technologies to navigate the changing landscape. In the complex world of insurance, particularly within workers’ compensation and auto insurance, the ability to make informed decisions is paramount. Bill review vendors like Enlyte play a crucial role in this process by providing detailed insights into billing trends and patterns.

Incorporating enhanced data analysis

One way payers can best prepare for these challenges is to partner with a company that offers advanced analytics services, including generative AI and machine learning. These technologies allow users to analyze large volumes of billing data in real-time and identify patterns and anomalies that might be missed by traditional methods. These include:

• Pharmaceutical cost monitoring
• Supply chain vulnerability detection
• Provider billing pattern analysis

Generative AI excels in helping payers understand the context and narrative of billing entries, ensuring appropriateness and compliance while allowing for human intervention and decision making for each case as needed. For example, it can recognize when similar treatments are coded differently across providers or identify when alternative therapies might be more cost-effective under new pricing structures.

Meanwhile, machine learning algorithms continuously learn from new data, improving accuracy and providing deeper insights into billing practices and trends. They can detect subtle shifts in utilization patterns that might indicate responses to policy changes, giving payers early warning of emerging cost drivers.

This comprehensive analytical approach is especially crucial as insurers grapple with potential cost increases due to delayed Medicare drug price negotiations and potential pharmaceutical tariffs, allowing them to make data-driven decisions in an uncertain regulatory environment.

Using trend analysis to make forward-looking decisions

A quality data analytics provider will prepare detailed reports on cost efficiency and compliance, supporting data-driven decision-making. At Enlyte, we identify billing patterns and trends to help payers anticipate future costs and adjust their strategies accordingly. For instance, in the context of delayed Medicare drug price negotiations and pharmaceutical tariffs, predictive analytics can help insurers anticipate and prepare for potential cost increases.

Generative AI powered by companies that have years of experience in the P&C industry should be able to adapt to new billing patterns and guidelines, continuously refining its algorithms to improve accuracy and compliance. This adaptability is crucial in a rapidly changing regulatory environment, such as the one created by the recent executive order. The integrated platforms can handle large volumes of data, making them scalable and adaptable to evolving billing practices, which is essential as insurers navigate the potential supply chain disruptions and shifts in drug availability.

Utilizing a comprehensive bill review ecosystem creates a connected data environment that can handle large volumes of information. This interconnected approach is essential as payers navigate supply chain disruptions and shifts in drug availability. By analyzing data across these systems, payers can:

• Identify emerging cost drivers before they significantly impact claims expenses;
• Detect shifts in provider billing practices following regulatory changes;
• Recognize geographic variations in how new policies affect healthcare delivery; and
• Anticipate medication availability issues and develop alternative treatment pathways.

This holistic approach to trend analysis transforms reactive cost management into proactive strategy development, particularly valuable during periods of regulatory uncertainty.

Integrating risk management and operational efficiency

Enhanced risk assessment is a key benefit of using qualified P&C bill review vendors. By identifying trends and patterns, they can help clients assess risks more accurately and adjust their pricing models accordingly. This capability is particularly valuable as insurers face potential increases in drug costs and supply chain uncertainties.

Advanced analytics can also detect fraudulent billing practices, ensuring compliance and reducing unnecessary costs. Automation of routine tasks and complex data analysis reduces manual intervention, streamlining the review process and improving efficiency. Identifying inefficiencies and redundant efforts leads to significant cost savings, allowing clients to allocate resources more strategically. This efficiency is crucial as insurers adapt to the changing health care landscape.

Utilizing regulatory and government affairs

These programs should also be supported by a partner that has its finger on the pulse of regulatory and legislative matters affecting the industry. These experts can prove to be powerful advocates and strategic partners, wielding legislative and regulatory expertise to shape the future of the insurance industry such as:

• Providing early insights into regulatory changes: Translating complex policy shifts into actionable strategies before they impact operations, similar to how the advanced analytics mentioned earlier identify billing patterns and trends
• Offering practical implementation guidance: Helping payers understand how theoretical policy changes will affect day-to-day operations, complementing the enhanced data analysis capabilities discussed earlier
• Creating strategic response frameworks: Developing approaches that turn regulatory challenges into opportunities, much like how trend analysis enables forward-looking decision-making
• Facilitating industry collaboration: Working with stakeholders to address practical application issues in existing regulations, which enhances risk-reduction strategies

When combined with advanced analytics, AI-powered trend analysis, and operational efficiency improvements, regulatory knowledge becomes the final piece in a comprehensive approach to managing future changes in the industry.

Lisa Robinson, EdD, MSHI, BSN-RN, is director of regulatory affairs at Enlyte. Michele Hibbert is senior vice president of Regulatory Compliance Management at Enlyte.

See also:

• 2025's multi-million-dollar MedMal verdicts so far
• Historic April flooding exposed homeowners insurance gaps
• Chubb's Greenberg appointed to Trump FEMA Review Council